NIH Trial Gives Surprising Boost to Chelation Therapy for Heart Disease
Ethylene diamine tetra-acetic acid (EDTA) chelation therapy is an intravenous treatment that involves repeated administrations of a synthetic amino acid to reduce atherosclerotic plaque and improve symptoms of cardiovascular disease.